CSF 5-HIAA and DST non-suppression -independent biomarkers in suicide attempters?

BACKGROUND Two major biomarkers of suicidal behaviour; low 5-hydroxyindoleacetic acid (5-HIAA) in the cerebrospinal fluid (CSF) and non-suppression in the dexamethasone suppression test (DST) have evidence for predictive power for suicide in mood disorders. Previous suicide attempt is the most robust clinical risk factor. PURPOSE OF STUDY To study the interrelationship of suicide risk factors: low CSF 5-HIAA and the DST non-suppression in mood disorder patients with and without an index suicide attempt. METHODS Fifty-eight hospitalised mood disorder patients (twenty-five with an index suicide attempt), who were not receiving any treatment with antidepressants, underwent lumbar puncture and DST. Plasma cortisol levels were determined from blood samples drawn the following day at 8:00 a.m., 4:00 p.m. and 11:00 p.m. and analysed in relation to CSF 5-HIAA. RESULTS In the sample as a whole, the serum cortisol level at 4:00 p.m. showed a significant positive correlation to CSF 5-HIAA (r=0.3, p<0.02). In the patients with an index suicide attempt, the serum cortisol at 4.00 p.m. correlated positively with CSF 5-HIAA (r=0.65, p<0.0006), but not in the non-attempters (NS). CONCLUSION The positive correlation means that low CSF 5-HIAA and DST non-suppression are relatively independent biomarkers of suicide risk in suicide attempters. The interrelation of the two systems seems to be different in suicide attempters compared to depressed inpatients without suicide attempt.

[1]  F. Holsboer,et al.  Hypothalamus-pituitary-adrenal system regulation and suicidal behavior in depression , 2005, Biological Psychiatry.

[2]  W. Coryell,et al.  Hyperactivity of the hypothalamic–pituitary–adrenal axis and mortality in major depressive disorder , 2006, Psychiatry Research.

[3]  M. Åsberg,et al.  Survival analysis of suicide risk after attempted suicide , 1995, Acta psychiatrica Scandinavica.

[4]  C. Alling,et al.  Prediction of Suicidal Behavior from Biologic Tests , 1992, Journal of clinical psychopharmacology.

[5]  G. Isacsson Depression is the core of suicidality – its treatment is the cure , 2006, Acta psychiatrica Scandinavica.

[6]  M. Linnoila,et al.  Cerebrospinal fluid monoamine metabolites and suicidal behavior in depressed patients. A 5-year follow-up study. , 1989, Archives of general psychiatry.

[7]  J. Mann,et al.  Can biological tests assist prediction of suicide in mood disorders? , 2006, The international journal of neuropsychopharmacology.

[8]  G. Keitner,et al.  The dexamethasone suppression test and completed suicide , 1990, Acta psychiatrica Scandinavica.

[9]  Jamie D. Feusner,et al.  The dexamethasone suppression test as a predictor of suicidal behavior in unipolar depression. , 2004, Journal of affective disorders.

[10]  S. Dahl,et al.  Clinical Pharmacology in Psychiatry , 1981, Palgrave Macmillan UK.

[11]  A. Young,et al.  Mood and neuropsychological function in depression: the role of corticosteroids and serotonin , 1998, Psychological Medicine.

[12]  D. Lester,et al.  The Concentration of Neurotransmitter Metabolites in the Cerebrospinal Fluid of Suicidal Individuals: a Meta-Analysis , 1995, Pharmacopsychiatry.

[13]  F. Chaouloff Physiopharmacological interactions between stress hormones and central serotonergic systems , 1993, Brain Research Reviews.

[14]  Å. Westrin,et al.  The dexamethasone suppression test and CSF-5-HIAA in relation to suicidality and depression in suicide attempters , 2003, European Psychiatry.

[15]  F. Chaouloff Serotonin, stress and corticoids , 2000, Journal of psychopharmacology.

[16]  A. Young,et al.  Corticosteroid-serotonin interactions in depression: a review of the human evidence , 2004, Psychopharmacology.

[17]  Lisa J. Martin,et al.  Genetics of monoamine metabolites in baboons: overlapping sets of genes influence levels of 5-hydroxyindolacetic acid, 3-hydroxy-4-methoxyphenylglycol, and homovanillic acid , 2004, Biological Psychiatry.

[18]  M. Åsberg,et al.  5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor? , 1976, Archives of general psychiatry.

[19]  W. Coryell,et al.  The dexamethasone suppression test and suicide prediction. , 2001, The American journal of psychiatry.

[20]  A. Nordström,et al.  CSF 5‐HIAA, suicide intent and hopelessness in the prediction of early suicide in male high‐risk suicide attempters , 2006, Acta psychiatrica Scandinavica.

[21]  O. Meijer,et al.  Corticosterone and serotonergic neurotransmission in the hippocampus: functional implications of central corticosteroid receptor diversity. , 1998, Critical reviews in neurobiology.

[22]  M. Åsberg,et al.  CSF 5-HIAA predicts suicide risk after attempted suicide. , 1994, Suicide & life-threatening behavior.

[23]  M. Oquendo,et al.  Prospective studies of suicidal behavior in major depressive and bipolar disorders: what is the evidence for predictive risk factors? , 2006, Acta psychiatrica Scandinavica.

[24]  F. Keller,et al.  Red-cell and serum folate levels in depressed inpatients who commit violent suicide: a comparison with control groups. , 1995, Pharmacopsychiatry.